Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U M Zanger

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
The Histochemical Journal|January 5, 2002
Distribution of microsomal epoxide hydrolase in humans: an immunohistochemical study in normal tissues, and benign and malignant tumoursJ K Coller, P Fritz, U M Zanger, et al.
Pharmacogenetics|August 1, 1997
Analysis of CYP2D6 expression in human lung: implications for the association between CYP2D6 activity and susceptibility to lung cancerK T Kivistö, E U Griese, T Stüven, et al.
Clinical Pharmacology and Therapeutics|October 2, 2009
UDP-glucuronosyltransferase (UGT) polymorphisms affect atorvastatin lactonization in vitro and in vivoS Riedmaier, K Klein, U Hofmann, et al.
Clinical Pharmacology and Therapeutics|November 8, 2013
Genetics, epigenetics, and regulation of drug-metabolizing cytochrome p450 enzymesU M Zanger, K Klein, M Thomas, et al.
Pharmacogenetics|July 27, 2001
Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liverT Lang, K Klein, J Fischer, et al.
European Journal of Clinical Pharmacology|September 11, 2001
Influence of CYP2D6 genotype and medication on the sparteine metabolic ratio of psychiatric patientsP L Lohmann, M L Rao, M Ludwig, et al.
Clinical Pharmacology and Therapeutics|March 9, 2007
Selective induction of human hepatic cytochromes P450 2B6 and 3A4 by metamizoleT Saussele, O Burk, J K Blievernicht, et al.
Gut|December 13, 2002
Safe treatment of thiopurine S-methyltransferase deficient Crohn's disease patients with azathioprineB A Kaskas, E Louis, U Hindorf, et al.
Nature|February 4, 1988
Characterization of the common genetic defect in humans deficient in debrisoquine metabolismF J Gonzalez, R C Skoda, S Kimura, et al.
Clinical Pharmacology and Therapeutics|January 20, 2007
Predictive value of known and novel alleles of CYP2B6 for efavirenz plasma concentrations in HIV-infected individualsM Rotger, H Tegude, S Colombo, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
The Histochemical Journal|January 5, 2002
Distribution of microsomal epoxide hydrolase in humans: an immunohistochemical study in normal tissues, and benign and malignant tumoursJ K Coller, P Fritz, U M Zanger, et al.
Pharmacogenetics|August 1, 1997
Analysis of CYP2D6 expression in human lung: implications for the association between CYP2D6 activity and susceptibility to lung cancerK T Kivistö, E U Griese, T Stüven, et al.
Clinical Pharmacology and Therapeutics|October 2, 2009
UDP-glucuronosyltransferase (UGT) polymorphisms affect atorvastatin lactonization in vitro and in vivoS Riedmaier, K Klein, U Hofmann, et al.
Clinical Pharmacology and Therapeutics|November 8, 2013
Genetics, epigenetics, and regulation of drug-metabolizing cytochrome p450 enzymesU M Zanger, K Klein, M Thomas, et al.
Pharmacogenetics|July 27, 2001
Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liverT Lang, K Klein, J Fischer, et al.
European Journal of Clinical Pharmacology|September 11, 2001
Influence of CYP2D6 genotype and medication on the sparteine metabolic ratio of psychiatric patientsP L Lohmann, M L Rao, M Ludwig, et al.
Clinical Pharmacology and Therapeutics|March 9, 2007
Selective induction of human hepatic cytochromes P450 2B6 and 3A4 by metamizoleT Saussele, O Burk, J K Blievernicht, et al.
Gut|December 13, 2002
Safe treatment of thiopurine S-methyltransferase deficient Crohn's disease patients with azathioprineB A Kaskas, E Louis, U Hindorf, et al.
Nature|February 4, 1988
Characterization of the common genetic defect in humans deficient in debrisoquine metabolismF J Gonzalez, R C Skoda, S Kimura, et al.
Clinical Pharmacology and Therapeutics|January 20, 2007
Predictive value of known and novel alleles of CYP2B6 for efavirenz plasma concentrations in HIV-infected individualsM Rotger, H Tegude, S Colombo, et al.
Pageof 6